Scynexis (SCYX) Shares Outstanding (Weighted Average) (2013 - 2026)

Scynexis (SCYX) reported Shares Outstanding (Weighted Average) of $51.0 million for Q1 2026, up 3.08% on a YoY basis from $49.4 million in Q1 2025, and up 2.05% quarter-over-quarter from $49.9 million in Q4 2025.

Scynexis (SCYX) Shares Outstanding (Weighted Average) (2013 - 2026) Analysis & Trends

Scynexis has reported Shares Outstanding (Weighted Average) for 14 years, with the latest figure at $51.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 3.08% year-over-year to $51.0 million; the trailing twelve-month figure through Mar 2026 stood at $51.0 million (up 3.08% YoY), and the FY2025 full-year result was $49.9 million, up 2.93% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $51.0 million, up from $49.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $51.0 million in Q1 2026, with the low at $32.1 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $46.4 million across 5 years, with a median of $48.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 61.51% — and 2024, when it advanced 1.02%.
  • Scynexis' Shares Outstanding (Weighted Average) stood at $42.6 million in 2022, then advanced by 12.29% to $47.9 million in 2023, then rose by 1.38% to $48.5 million in 2024, then rose by 2.93% to $49.9 million in 2025, then grew by 2.05% to $51.0 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $51.0 million (Q1 2026), $49.9 million (Q4 2025), and $49.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Scynexis 225.23 Mn 165.97 Mn - 50.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.96 Mn
Dec 31, 2025 49.93 Mn
Sep 30, 2025 49.90 Mn
Jun 30, 2025 49.75 Mn
Mar 31, 2025 49.44 Mn
Dec 31, 2024 48.51 Mn
Sep 30, 2024 48.46 Mn
Jun 30, 2024 48.51 Mn
Mar 31, 2024 48.25 Mn
Dec 31, 2023 47.85 Mn
Sep 30, 2023 47.89 Mn
Jun 30, 2023 47.80 Mn
Mar 31, 2023 47.76 Mn
Dec 31, 2022 42.61 Mn
Sep 30, 2022 40.97 Mn
Jun 30, 2022 37.65 Mn
Mar 31, 2022 32.05 Mn
Dec 31, 2021 26.38 Mn
Sep 30, 2021 26.15 Mn
Jun 30, 2021 26.02 Mn